Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of immunotherapy and molecular‑targeted therapy in the treatment of melanoma (Review)
Paulina Stachyra‐Strawa, Marzanna Ciesielka, Michał Janiszewski, et al.
Oncology Reports (2021) Vol. 46, Iss. 2
Open Access | Times Cited: 17

Showing 17 citing articles:

Managing Metastatic Melanoma in 2022: A Clinical Review
Benjamin Switzer, Igor Puzanov, Joseph J. Skitzki, et al.
JCO Oncology Practice (2022) Vol. 18, Iss. 5, pp. 335-351
Open Access | Times Cited: 147
Dendritic Cell-Derived Exosomes Driven Drug Co-Delivery Biomimetic Nanosystem for Effective Combination of Malignant Melanoma Immunotherapy and Gene Therapy
Jiecheng Lin, Na Huang, Mingjuan Li, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 2087-2106
Open Access | Times Cited: 14
Targeting the EGFR/RAS/RAF signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)
Rima Hajjo, Dima A. Sabbah, Sanaa K. Bardaweel, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 1-2, pp. 51-69
Closed Access | Times Cited: 5
Research progress on hydrogel-based drug therapy in melanoma immunotherapy
Wei He, Yanqin Zhang, Yi Qu, et al.
BMB Reports (2024) Vol. 57, Iss. 2, pp. 71-78
Open Access | Times Cited: 4
Antitumor Activities of Interleukin-12 in Melanoma
Wei Gao, Jun Pan, Jianping Pan
Cancers (2022) Vol. 14, Iss. 22, pp. 5592-5592
Open Access | Times Cited: 17
The Assessment of Anti-Melanoma Potential of Tigecycline—Cellular and Molecular Studies of Cell Proliferation, Apoptosis and Autophagy on Amelanotic and Melanotic Melanoma Cells
Jakub Rok, Justyna Kowalska, Zuzanna Rzepka, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1564-1564
Open Access | Times Cited: 7
Cardiac and Nephrological Complications Related to the Use of Antiangiogenic and Anti-Programmed Cell Death Protein 1 Receptor/Programmed Cell Death Protein 1 Ligand Therapy
Paulina Stachyra‐Strawa, Lidia Szatkowska-Sieczek, Paweł Cisek, et al.
Genes (2024) Vol. 15, Iss. 2, pp. 177-177
Open Access | Times Cited: 2
Current Controversies in Melanoma Treatment
Claire Temple‐Oberle, Christine Nicholas, Priscila Rojas-García
Plastic & Reconstructive Surgery (2023) Vol. 151, Iss. 3, pp. 495e-505e
Closed Access | Times Cited: 6
Immunotherapy and delivery systems for melanoma
Hui Liu, Xi Gou, Yuanfang Tan, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Ruthenium(II) complex with 2-mercaptothiazoline ligand induces selective cytotoxicity involving DNA damage and apoptosis in melanoma cells
Matheus Reis Santos de Melo, Arthur Barcelos Ribeiro, Gabriela Souza Fernandes, et al.
JBIC Journal of Biological Inorganic Chemistry (2024) Vol. 29, Iss. 1, pp. 159-168
Closed Access | Times Cited: 1
Exogenous Hydrogen Sulfide Induces A375 Melanoma Cell Apoptosis Through Overactivation of the Unfolded Protein Response
Weiyuan Ma, Xiuwen Zhang, Le Zhuang
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 1641-1651
Open Access | Times Cited: 3
Outcomes of Patients with Metastatic Melanoma—A Single-Institution Retrospective Analysis
Lidia Szatkowska, Jan Sieczek, Katarzyna Tekiela, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1672-1672
Open Access | Times Cited: 3
Integrative analysis of microRNA-mediated mitochondrial dysfunction in hippocampal neural progenitor cell death in relation with Alzheimer's disease.
Arum Han, Tae Kwon Moon, Im Kyeung Kang, et al.
PubMed (2024) Vol. 57, Iss. 6, pp. 281-286
Closed Access
PARVB promotes malignant melanoma progression and is enhanced by hypoxic conditions
Ting Wang, Zhiqiang Wu, Yifeng Bi, et al.
Translational Oncology (2024) Vol. 42, pp. 101861-101861
Open Access
Nidogen-2 (NID2) is a Key Factor in Collagen Causing Poor Response to Immunotherapy in Melanoma
Yan Sha, An-qi Mao, Yuan-jie Liu, et al.
Pharmacogenomics and Personalized Medicine (2023) Vol. Volume 16, pp. 153-172
Open Access | Times Cited: 1
C118P exerted potent anti-tumor effects against melanoma with induction of G2/M arrest via inhibiting the expression of BUB1B
Kun Ren, Meng Zhou, Lingjun Li, et al.
Journal of Dermatological Science (2022) Vol. 108, Iss. 2, pp. 58-67
Closed Access | Times Cited: 1
Development and Evaluation of Novel Deoxyhypusine Synthase (Dhps) Inhibitors as a New Strategy for Melanoma Treatment: In Vitro and in Vivo
Xinyang Li, Kai-li Liu, Jing-si Guo, et al.
(2023)
Closed Access
Page 1

Scroll to top